A carregar...
Raloxifene administration enhances retention in an orthodontic relapse model
BACKGROUND AND OBJECTIVES: Orthodontic relapse is a physiologic process that involves remodelling of the alveolar bone and principle periodontal ligament fibres. Raloxifene is an Food and Drug Administration (FDA)-approved selective oestrogen receptor modulator that inhibits systemic bone loss. In o...
Na minha lista:
| Publicado no: | Eur J Orthod |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7485273/ https://ncbi.nlm.nih.gov/pubmed/32065225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ejo/cjaa008 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|